LAWSON BYRON (SVP/Chief Commercial Officer) received a stock award from HTG MOLECULAR DIAGNOSTICS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/15/2022ACC: 0001209191-22-036956
Officer· SVP/Chief Commercial Officer
Since Jan 2020
+1K
Net shares
Net buyer
$476.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1K
Price / share
$0.48
Trade value
$476.00
% of position
24.7%
6/10/2022
4.06K→5.06K
Total
Net shares
+1K
Net value
$476.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2022 | A · Award | +1K | $0.48 | $476.00 | 24.7% | 4.06K | 5.06K |
| Total | +1K | $476.00 | ||||||
Derivative Transactions0
No derivative transactions reported